General Counsel Greg Boss of global biotherapeutics leader CSL Limited today accepted the World Recognition of Distinguished General Counsel from the Directors Roundtable in recognition of his professional accomplishments and passion for ethical leadership.
“The General Counsel is more important today than ever in history. Boards of Directors increasingly look to the General Counsel to enhance financial and business strategy, compliance, and integrity of corporate operations, so we are pleased to gather some of the leading corporate advisors on the East Coast to recognize Greg with this distinguished honor,” said Jack Friedman, Chairman, Directors Roundtable.
At an awards event in Philadelphia, Boss shared insights on how his position can help a global company like CSL deliver on its promises:
“The role of the General Counsel is to help advise and counsel the organization through a challenging environment, while staying true to our values and delivering on our promises to patients, partners, and shareholders,” Boss said. “I’m very proud to say that the legal team at CSL plays a pivotal role in helping to create a culture where people are encouraged and empowered to live our values.”
The General Counsel’s office helps CSL navigate regulatory changes in more than 60 countries, private and public payer austerity measures, intellectual property challenges, advances in digital health and countless other issues.
Boss noted that, as CSL marks its 100th anniversary in 2016, the company’s 16,000-plus employees work every day as if someone’s life depends on it.
“No matter where someone sits within the CSL organization, our work is driven by our passion in making a difference in the lives of people who we treat,” he said. “When we say we’re going to do something, we do it.”
Leaders from area companies attended the event, as well as partners from Philadelphia-area law firms, who provided their perspectives on the challenges and opportunities that General Counsel and their advisors must navigate in today’s business climate.
CSL is a leading global biotherapeutics company with a dynamic portfolio of life-saving innovations, including those that treat haemophilia and immune deficiencies, as well as vaccines to prevent influenza. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL — including our two businesses CSL Behring (based in King of Prussia, PA) and Seqirus — conducts business in over 60 countries with more than 16,000 employees. Our unique combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live life to the fullest.
The Directors Roundtable organizes the preeminent worldwide programming for corporate directors and their advisors. It has created the leading forum for Directors to discuss their concerns with peers and distinguished experts. The challenging topics focus on key developments, regulations, and pragmatic solutions directly impacting their company and their roles. Since 1991, it has organized more than 600 events worldwide.
Natalie de Vane
Mobile: +1 610 999 8756
Boardwalk Public Relations
Mobile: +1 610 764 1301